[1] Xu Y,Wang L, He J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959. [2] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013版)[J].中华糖尿病杂志,2014, 6(7): 447-498. [3] Bertelsen G,Peto T,Lindekleiv H,et al.Troms eye study: prevalence and risk factors of diabetic retinopathy[J].Acta Ophthalmol,2013,91(8):716-721. [4] Gabir MM, Hanson RL, Dabelea d, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and predition of diabetes[J].Diabetes Care,2000, 23(8):1108-1112. [5] 胡泓,李红,郑芬萍,等.不同神经病变评分系统在无症状糖尿病周围神经病变筛查中的临床价值比较[J].中华内科杂志,2012,51:13-17. [6] 中国医学会糖尿病学分会.2011版中国型糖尿病防治栺南中华内分泌指南[J].中华内分泌代谢杂志,2011,12(27):21-28. [7] Liu L,Wu X,Liu L,et al.Prevalence of diabetic retinopathy in mainland China: a meta-analysis[J].PLoS One,2012,7(9):e45264. [8] 中国医学会糖尿病学分会.中国2型糖尿病防治指南(2010年版)[J].中国糖尿病杂志,2012,20(1): 1-37. [9] 张竖,姜士军,蒋 燕玲,等.周边视网膜光凝治疗中度非增殖期糖尿病视网膜病变的临床疗效观察[J].中华眼科医学杂志,2015,5(1):27-31. [10] 余芳,朱惠平.2型糖尿病患者血糖波动与糖尿病视网膜病变的相关性研究[J].医学临床研究,2012,29(8):1547-1549. [11] Deissler HL, Lang GE. Effect of VEGF165 and the VEGF aptamer pegaptanib (Macugen) on the protein composition of tight junctions in microvascular endothelial cells of the retina[J].Klin Monbl Augenheilkd,2011,225(10):863-867. [12] Thomas RL, Dunstan FD, Luzio SD, et al. Prevalence of diabetic retinopathy within a national diabetic retinopathyscreening service[J].Br J Ophthalmol,2015,99(1):64-68. [13] Mowatt L. Diabetic retinopathy and its risk factors at the university hospital in Jamaica[J] .Middle East Afr J Ophthalmol,2013,20(4):321-326. [14] Abougalambou SS, Abougalambou AS. Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia[J].Diabetes Metab Syndr,2015,9(2):98-103. [15] 包玉倩.糖化血红蛋白临床应用解析[J].中华糖尿病杂志,2013,5(1):11-14.
2017, Vol. 34 
